Login / Signup

Synergistic effects of the galanin analog 810-2 with the antiseizure medication levetiracetam in rodent seizure models.

Cameron S MetcalfSaurabh GagangrasGrzegorz BulajH Steve White
Published in: Epilepsia (2022)
The combination of 810-2 with LEV suggests the potential for this galanin analog to be further developed as an add-on therapy for patients with epilepsy, particularly when coadministered with LEV.
Keyphrases
  • temporal lobe epilepsy
  • healthcare
  • adverse drug
  • human health
  • climate change